Careers and Recruitment in 2003

Job growth in HIV research is shifting from laboratories in the developed world to the regions most affected by AIDS. Myrna Watanabe reports

Nanoscience is fragmenting into tinier pieces, but there are great expectations everywhere. Myrna Watanabe investigates.

Rapidly changing technology and an abundance of DNA sequences are creating more job opportunities in functional genomics — particularly for scientists who have been trained outside traditional biology. Hannah Hoag investigates.

The costs of functional genomics can be prohibitive, and job candidates often lack the skills most researchers desire, but many academic settings are creating training schemes and unique institutes to deal with these barriers. Hannah Hoag reports.

The United States may have more coordinated funding, but Europe is taking the lead in training biomedical engineers. Ralf Jox reports.

Prospects are good for biomedical engineers across industry — and there's still room for entrepreneurs, say Ralf Jox and Virginia Gewin.

Steady philanthropic support, new federal funding and increased commercial interest are mixing in the United States to create a large and growing number of opportunities for a new breed of multidisciplinary researcher, says Virginia Gewin.

Medicinal chemists are in demand more than ever before — but the vagaries of the drug-discovery market and a sluggish economy have dampened prospects temporarily, says Eugene Russo.

Medicinal chemists have skills that are eagerly snapped up by industry, and an increase in training options is making it easier to gain the necessary experience. Eugene Russo reports.

Improving proteomic techniques will tackle questions in cell biology, signal transduction and clinical research. But workers with the key knowledge in protein biochemistry, mass spectrometry and bioinformatics are hard to find, says Kendall Powell.

Current economic conditions are putting a strain on the nascent world of proteomics. But many companies are managing to flourish by carving out their own market niche. Kendall Powell investigates.

The European Union has dreams of becoming a centralized scientific powerhouse. But first it needs to solve its brain-drain problem. Quirin Schiermeier reports.

The doubling of public funds for life-science research in the United States has increased the number of postdocs, but it has yet to create significantly more permanent academic positions, says Eugene Russo.

Making sense of the reams of information streaming out of genome projects requires a sophisticated blend of biology and physics, says Kendall Powell.